Clinical Trial Update: Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis [Phase 1]

View source ↗

Summary

A Phase 1 trial of intraperitoneal paclitaxel-loaded TPM for peritoneal carcinomatosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Carlos Chan | Conditions: Peritoneal Carcinomatosis | Phase 1 | Status: TERMINATED